Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.

They showed a trend toward reduction of MI, TLF, and stent thrombosis (ST) for patients treated with BP‐SES. 14 Zhu et al. considered six RCTs comparing BP‐SES with two different durable polymer stents for the meta‐analysis, in which a significantly reduced risk for MI in BP‐SES treated subjects was found. 15 As the majority of these analyses was performed at publication level, detailed analyses of different patient subgroups were not possible.

also in 53,322 other papers